UBS Group Raises UnitedHealth Group (NYSE:UNH) Price Target to $680.00

UnitedHealth Group (NYSE:UNH) had its target price upped by equities research analysts at UBS Group from $640.00 to $680.00 in a research note issued on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the healthcare conglomerate’s stock. UBS Group’s price target indicates a potential upside of 20.03% from the stock’s previous close.

A number of other analysts have also recently commented on UNH. JPMorgan Chase & Co. boosted their price objective on UnitedHealth Group from $546.00 to $559.00 and gave the company an “overweight” rating in a research report on Thursday, May 30th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research report on Wednesday. Royal Bank of Canada raised their price target on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a research note on Wednesday. Morgan Stanley increased their target price on UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $612.00.

UnitedHealth Group Stock Performance

NYSE:UNH traded down $6.75 during mid-day trading on Thursday, hitting $566.53. The company’s stock had a trading volume of 3,596,011 shares, compared to its average volume of 4,333,004. The business’s fifty day moving average is $502.36 and its two-hundred day moving average is $500.29. The stock has a market cap of $521.43 billion, a price-to-earnings ratio of 34.38, a PEG ratio of 1.61 and a beta of 0.60. UnitedHealth Group has a 1 year low of $436.38 and a 1 year high of $581.31. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.88 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. The company had revenue of $98.86 billion during the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. UnitedHealth Group’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period last year, the business earned $6.14 earnings per share. Analysts anticipate that UnitedHealth Group will post 27.68 EPS for the current fiscal year.

Institutional Investors Weigh In On UnitedHealth Group

A number of institutional investors have recently modified their holdings of the company. Naples Global Advisors LLC boosted its stake in shares of UnitedHealth Group by 3.7% in the second quarter. Naples Global Advisors LLC now owns 14,084 shares of the healthcare conglomerate’s stock valued at $7,173,000 after purchasing an additional 504 shares during the period. Cordatus Wealth Management LLC grew its stake in shares of UnitedHealth Group by 0.5% in the second quarter. Cordatus Wealth Management LLC now owns 9,985 shares of the healthcare conglomerate’s stock worth $5,085,000 after acquiring an additional 49 shares in the last quarter. Verde Capital Management raised its stake in shares of UnitedHealth Group by 21.5% in the second quarter. Verde Capital Management now owns 804 shares of the healthcare conglomerate’s stock valued at $410,000 after acquiring an additional 142 shares in the last quarter. Ellsworth Advisors LLC grew its stake in UnitedHealth Group by 10.7% during the 2nd quarter. Ellsworth Advisors LLC now owns 1,228 shares of the healthcare conglomerate’s stock worth $625,000 after purchasing an additional 119 shares in the last quarter. Finally, Triad Wealth Partners LLC raised its position in UnitedHealth Group by 23.5% in the 2nd quarter. Triad Wealth Partners LLC now owns 1,695 shares of the healthcare conglomerate’s stock valued at $863,000 after purchasing an additional 323 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.